Table 3.
Point prevalence study: most frequent combinations of sedative and analgesic agents and single sedative/analgesic agents
| Sedative/analgesic agents | n (%) |
|---|---|
| Most frequenta combinations of sedative and analgesicb agents | |
| Propofol and alfentanil | 49 (20.3) |
| Propofol and fentanyl | 44 (18.2) |
| Propofol and remifentanil | 12 (5.0) |
| Propofol and morphine | 10 (4.1) |
| Propofol, midazolam and alfentanil | 4 (1.7) |
| Propofol, midazolam and fentanyl | 4 (1.7) |
| Propofol, clonidine and alfentanil | 3 (1.2) |
| Most frequenta single sedative agents | |
| Propofol | 15 (6.2) |
| Clonidine | 5 (2.1) |
| Most frequenta single analgesicb agents | |
| Morphine | 22 (9.1) |
| Fentanyl | 8 (3.3) |
| Alfentanil | 5 (2.1) |
| Remifentanil | 4 (1.7) |
a Combinations/single agents included only if reported for at least three patients
b With or without additional paracetamol, codeine or bupivacaine